Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05497960
Other study ID # Pro00110021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date May 15, 2023

Study information

Verified date July 2023
Source Impactiv, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research trial studies the effect of an online, live and interactive strength training program on physical function and strength in older adults with prediabetes.


Description:

It is well established that in-person resistance training is an effective form of exercise to increase physical function and quality of life amongst adults. However, older adults report not participating in resistance training due to lack of age appropriate programs, fear of a gym setting, poor access to a gym, joint and other kinds of pain, and lack of social support. These barriers have been compounded as a result of COVID-19 panedmic, wherein older adults are encouraged to socially isolate, leading to even less physical activity. Vivo is a virtual small group exercise program designed for adults 55 and addresses these major barriers to strength training by coaching through an interactive online training session incorporating social support and social engagement. The investigators plan is to test a highly attractive technology platform specifically designed to meet the needs of older adults to demonstrate that resistance training exercise can be scaled and effective with diverse older adults and remove the barrier of having to go to a gym setting to see benefits. The investigators will demonstrate efficacy in a real world sample of adults ≥60 with prediabetes, a very prevalent, serious and often silent health condition that affects 1 in 3 adults in the US and is associated with high rates of sarcopenia, or loss of muscle mass. To do so, the investigators will conduct a clinical trial to determine the effectiveness of Vivo verses a wait list control on glucose control, physical function, social engagement, adherence and quality of life in hopes of preventing the progression from prediabetes to Type 2 diabetes.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date May 15, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Age = 60 years; - Diagnosis of Pre-diabetes within prior 12 months: fasting glucose between 100 to 126 OR HbA1c between 5.7 and 6.4% - Ambulatory and community-dwelling - Sedentary: less than 150 minutes of moderate physical activity OR less than 75 minutes of vigorous physical activity per week - Have not engaged in resistance training for at least 6 months prior to enrollment - Low functioning (defined as able to do at least 1 chair stand without using hand in 30 second but unable to meet the moderate function criteria for age and gender) - Access to WiFi (or internet connection) in defined exercise space - Willing to maintain weight and current diet throughout the study Exclusion Criteria: - Inability to complete physical function assessment or inability to do a chair stand without using hands. - Use of antidiabetic medications - Use of testosterone supplement or replacement - Clinical disorder precluding/interfering with participation or assessments - Unstable angina, arrhythmia, uncontrolled hypertension - End Stage Renal Disease on Hemodialysis - Lower extremity amputation or paralysis - Neurological conditions causing functional or pronounced cognitive impairments - Active malignancy except for non-melanomatous skin cancers - Unable to provide consent - Weight instability

Study Design


Intervention

Behavioral:
Vivo workout
2 days a week for 12 weeks of a live, interactive virtual strength training program. Each class is 45 minutes long and lead by a certified trainer.

Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Eric Levian Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intervention engagement assess by workout attendance older adults with prediabetes workout attendance will be measured, reasons for missed workouts will be collected participation; b) ease of use; and c) overall satisfaction. Milestone 2: Assess trainer fidelity 3 months
Primary Intervention engagement assessed by self- reported barriers and facilitators Participants will complete questions to answer their comfort level with using the technology platform functional specifications of the client-centered approach (results, goals, adherence, upcoming workouts), and social engagement and support. Milestone 2: Develop a clickable prototype of the platform. 3 months
Primary Program satisfaction Participants will complete a questionnaire to answer "how satisfied are you with the program" 3 months
Secondary Leg strength assessed through a 30 second chair rise test Participants will complete as many chair stands as they can in 30 seconds 3 months
Secondary Health-related quality of life measured via the Short Form (SF)-36 Change from baseline to 3 months will be assessed (scores range from 0-100 with higher scores indicating better health-related quality of life) 3 months
Secondary Sleep measured via the Pittsburgh Sleep Quality Index (PSQI) Change from baseline to 3 months (PSQI scores range from 0-21 with higher scores indicating worse sleep quality) 3 months
Secondary Satisfaction with Life measured by the 5 item SWL questionnaire Changes from baseline to 3 months (SWL scores range from 5-35 with higher score indicating greater SWL) 3 months
Secondary Exercise Efficacy Changes from baseline to 3 months will be assessed using a questionnaire measuring the participant's confidence in completing exercise related behaviors 3 months
Secondary Profile of Mood Survey (POMS) Changes from baseline to 3 months will assess participant's changes in mood. 3 months
Secondary Perceived Stress Scale Center for Epidemiologic Studies Depression Scale (CES-D) Changes from baseline to 3 months will assess participant's changes in perceived stress. likert scale from 0-4, higher scores indicate higher stress 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Completed NCT03188263 - Morning Light Treatment to Improve Glucose Metabolism N/A
Recruiting NCT03821961 - 18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery N/A
Completed NCT04303468 - Intervention With a GABA Supplement in Prediabetics N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT01910051 - Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Completed NCT03527368 - The Time-Restricted Intake of Meals Study N/A
Not yet recruiting NCT06453278 - (DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
Completed NCT03865342 - Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program N/A
Completed NCT02899390 - Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes N/A
Suspended NCT03240978 - Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese N/A
Recruiting NCT01972113 - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study) N/A
Completed NCT01432509 - Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord) N/A
Completed NCT01436916 - Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus Phase 4
Completed NCT00990184 - Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes) Phase 3
Completed NCT00886340 - A Lifestyle Change Program to Prevent Type 2 Diabetes Phase 2